Cargando…
The use of Xuanbai Chengqi decoction on monkeypox disease through the estrone-target AR interaction
INTRODUCTION: After COVID-19, there was an outbreak of a new infectious disease caused by monkeypox virus. So far, no specific drug has been found to treat it. Xuanbai Chengqi decoction (XBCQD) has shown effects against a variety of viruses in China. METHODS: We searched for the active compounds and...
Autores principales: | Jiao, Yanqi, Shi, Chengcheng, Sun, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553791/ https://www.ncbi.nlm.nih.gov/pubmed/37808322 http://dx.doi.org/10.3389/fmicb.2023.1234817 |
Ejemplares similares
-
Effects of Xuanbai Chengqi decoction on lung compliance for patients with exogenous pulmonary acute respiratory distress syndrome
por: Mao, Zhengrong, et al.
Publicado: (2016) -
Chemical composition and therapeutic mechanism of Xuanbai Chengqi Decoction in the treatment of COVID-19 by network pharmacology, molecular docking and molecular dynamic analysis
por: Fan, Liming, et al.
Publicado: (2022) -
Xuanbai Chengqi Decoction Ameliorates Pulmonary Inflammation via Reshaping Gut Microbiota and Rectifying Th17/Treg Imbalance in a Murine Model of Chronic Obstructive Pulmonary Disease
por: Wang, Yongan, et al.
Publicado: (2021) -
The Efficacy and Safety of Xinjia Xuanbai Chengqi Granules in Acute Exacerbation of COPD: A Multicentre, Randomised, Double-Blind, Controlled Trial
por: Qi, Ruihan, et al.
Publicado: (2022) -
Effects of Chengqi Decoction on Complications and Prognosis of Patients with Pneumonia-Derived Sepsis: Retrospective Cohort Study
por: Huang, Zhipeng, et al.
Publicado: (2021)